BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6753100)

  • 1. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
    Holmberg L; Kristoffersson AC; Lecander I; Wallén P; Astedt B
    Scand J Clin Lab Invest; 1982 Jun; 42(4):347-54. PubMed ID: 6753100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures.
    Astedt B; Holmberg L; Lecander I; Thorell J
    Eur J Cancer (1965); 1981 Feb; 17(2):239-44. PubMed ID: 7021161
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
    Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
    Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
    De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
    J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.
    Kohga S; Harvey SR; Weaver RM; Markus G
    Cancer Res; 1985 Apr; 45(4):1787-96. PubMed ID: 3884145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activation system in active even in thyroid tumors; an immunohistochemical study.
    Ito Y; Takeda T; Kobayashi T; Wakasugi E; Tamaki Y; Umeshita K; Monden T; Shimano T; Monden M
    Anticancer Res; 1996; 16(1):81-9. PubMed ID: 8615674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
    Rijken DC; Juhan-Vague I; de Cock F; Collen D
    J Lab Clin Med; 1983 Feb; 101(2):274-84. PubMed ID: 6681623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine embryos produce a urokinase-type plasminogen activator.
    Berg DA; Menino AR
    Mol Reprod Dev; 1992 Jan; 31(1):14-9. PubMed ID: 1562322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on tissue culture plasminogen activator. II. The detection and assay of urokinase and plasminogen activator from LLC-PK cultures (porcine) by the synthetic substrate Nalpha-benzyloxycarbonyl-glycyl-glycyl-arginyl-4-methoxy-2-napthylamide.
    Huseby RM; Clavin SA; Smith RE; Hull RN; Smithwick EL
    Thromb Res; 1977 May; 10(5):679-87. PubMed ID: 882957
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.
    Holst-Hansen C; Hamers MJ; Johannessen BE; Brünner N; Stephens RW
    Br J Cancer; 1999 Sep; 81(2):203-11. PubMed ID: 10496343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.
    Björlin G; Ljungnér H; Wennerberg J; Astedt B
    Acta Otolaryngol; 1987; 104(5-6):568-72. PubMed ID: 3434279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.
    Markus G; Camiolo SM; Kohga S; Madeja JM; Mittelman A
    Cancer Res; 1983 Nov; 43(11):5517-25. PubMed ID: 6193874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.